Free Trial
NASDAQ:NTRB

Nutriband (NTRB) Stock Price, News & Analysis

Nutriband logo
$5.48 -0.25 (-4.36%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$5.50 +0.02 (+0.35%)
As of 05/23/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Nutriband Stock (NASDAQ:NTRB)

Key Stats

Today's Range
$5.32
$5.75
50-Day Range
$4.72
$6.88
52-Week Range
$3.72
$11.78
Volume
21,969 shs
Average Volume
77,227 shs
Market Capitalization
$61.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.00
Consensus Rating
Buy

Company Overview

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Nutriband Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

NTRB MarketRank™: 

Nutriband scored higher than 38% of companies evaluated by MarketBeat, and ranked 678th out of 918 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nutriband has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Nutriband has received no research coverage in the past 90 days.

  • Read more about Nutriband's stock forecast and price target.
  • Earnings Growth

    Earnings for Nutriband are expected to grow in the coming year, from ($0.60) to ($0.56) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nutriband is -7.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nutriband is -7.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Nutriband has a P/B Ratio of 7.51. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Nutriband's valuation and earnings.
  • Percentage of Shares Shorted

    3.80% of the float of Nutriband has been sold short.
  • Short Interest Ratio / Days to Cover

    Nutriband has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nutriband has recently increased by 6.68%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Nutriband does not currently pay a dividend.

  • Dividend Growth

    Nutriband does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.80% of the float of Nutriband has been sold short.
  • Short Interest Ratio / Days to Cover

    Nutriband has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nutriband has recently increased by 6.68%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Nutriband this week, compared to 1 article on an average week.
  • MarketBeat Follows

    13 people have added Nutriband to their MarketBeat watchlist in the last 30 days. This is an increase of 1,200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nutriband insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    54.09% of the stock of Nutriband is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 19.70% of the stock of Nutriband is held by institutions.

  • Read more about Nutriband's insider trading history.
Receive NTRB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutriband and its competitors with MarketBeat's FREE daily newsletter.

NTRB Stock News Headlines

Nutriband (NASDAQ: NTRB) Charts Path to Commercialization
Volatility Is Rising—But These 2 AI Stocks Could Thrive
2025 is off to a turbulent start—markets are swinging wildly, inflation pressures remain high, and recession fears are creeping back into headlines. But even in uncertain times, innovation doesn’t slow down. In fact, artificial intelligence (AI) is accelerating faster than ever—creating new profit opportunities while the broader market struggles. Our latest research reveals two AI stocks trading under $15 that could thrive even as volatility grows. These under-the-radar companies are positioned to ride the next wave of AI-driven demand—and they’re still flying below most investors’ radar.
Nutriband CEO Publishes Letter to Shareholders
Nutriband granted patent in Macao for its AVERA systems
See More Headlines

NTRB Stock Analysis - Frequently Asked Questions

Nutriband's stock was trading at $4.71 at the beginning of the year. Since then, NTRB shares have increased by 16.3% and is now trading at $5.48.
View the best growth stocks for 2025 here
.

Nutriband Inc. (NASDAQ:NTRB) issued its quarterly earnings results on Monday, April, 28th. The company reported ($0.18) earnings per share for the quarter, missing analysts' consensus estimates of ($0.12) by $0.06. The firm earned $0.64 million during the quarter, compared to the consensus estimate of $0.71 million. Nutriband had a negative trailing twelve-month return on equity of 54.49% and a negative net margin of 338.51%.

Nutriband shares split on the morning of Monday, August 15th 2022. The 13-6 split was announced on Monday, August 15th 2022. The newly created shares were distributed to shareholders after the closing bell on Monday, August 15th 2022. An investor that had 100 shares of stock prior to the split would have 217 shares after the split.

Nutriband's top institutional investors include US Bancorp DE (0.04%).

Shares of NTRB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nutriband investors own include Jiuzi (JZXN), AMC Entertainment (AMC), Aridis Pharmaceuticals (ARDS), Avenue Therapeutics (ATXI), Esports Entertainment Group (GMBL), Moleculin Biotech (MBRX) and ARMOUR Residential REIT (ARR).

Company Calendar

Last Earnings
4/28/2025
Today
5/25/2025
Next Earnings (Estimated)
5/30/2025
Fiscal Year End
1/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NTRB
Fax
N/A
Employees
10
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.00
High Stock Price Target
$13.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+137.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-5,490,000.00
Net Margins
-338.51%
Pretax Margin
-338.46%

Debt

Sales & Book Value

Annual Sales
$2.14 million
Price / Cash Flow
N/A
Book Value
$0.73 per share
Price / Book
7.51

Miscellaneous

Free Float
5,099,000
Market Cap
$61.12 million
Optionable
Not Optionable
Beta
1.18
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:NTRB) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners